Folks who take the blockbuster weight-loss med tirzepatide (Zepbound) may regain much of the weight they lost soon after discontinuing it, new research shows. A trial funded by Eli Lilly, the injected drug’s maker, found that “in patients with obesity or overweight, withdrawing tirzepatide led to substantial regain of weight.” On the other hand, continuing…  read on >  read on >

FRIDAY, Dec. 8, 2023 (Healthday News) — A salmonella outbreak tied to tainted cantaloupes keeps expanding, with cases doubling since the last tally, U.S. health officials reported Thursday. “Since the last update [on] November 30, 2023, an additional 113 people infected with this outbreak strain of salmonella have been reported from four additional states, resulting in a…  read on >  read on >

The newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday. “Today opens another chapter for adults living with obesity who have been looking for a new treatment option like Zepbound,” Rhonda Pacheco, group vice president of Lilly Diabetes and Obesity, U.S., said in a company news…  read on >  read on >

Teenagers with epilepsy are more likely to have an eating disorder than those not suffering from the brain disease, a new study shows. About 8.4% of children ages 10 to 19 treated at a Boston epilepsy clinic had eating disorders, three times the national average of 2.7% of teens with an eating disorder, researchers found.…  read on >  read on >

A new study of identical twins has provided fresh evidence that a vegan diet can vastly improve a person’s heart health. Twins assigned a vegan diet for two months had significant improvements in cholesterol, insulin and body weight compared to their siblings, who ate a healthy diet that included animal protein. “Based on these results…  read on >  read on >